Acquiring Company
QOL Medical
Acquired Company
Evoke Pharma
Description
QOL Medical announced the successful completion of its acquisition of Evoke Pharma, with the transaction concluding on December 15, 2025. Evoke shareholders received $11.00 per share in cash as part of the deal, and Evoke now operates as a wholly owned subsidiary of QOL Medical. The shares of Evoke will be delisted from Nasdaq following the merger.
Quick answer
QOL Medical is acquiring Evoke Pharma, announced December 17, 2025. QOL Medical is based in Vero Beach, Florida, United States.
- How much did QOL Medical pay for Evoke Pharma?
- The deal value was not disclosed.
- What does QOL Medical do?
- QOL Medical is a specialty biopharmaceutical company committed to delivering solutions for rare diseases.
- Where are QOL Medical and Evoke Pharma based?
- QOL Medical is based in Vero Beach, Florida, United States. Evoke Pharma is based in Solana Beach, California, United States.
- Who are the decision-makers at QOL Medical?
- Fundz holds 2 contacts at QOL Medical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Revolution Medicines soon (January 9, 2026)
- Halozyme acquires Surf Bio for $300 million, $300M (January 28, 2026)
- Pfizer completes $43 billion acquisition of Seagen, $43B (January 4, 2026)
- Sanofi acquires Dynavax Technologies for $15.50/share (December 24, 2025)
- Great Point Partners buys majority stake in Lenis Group (December 10, 2025)
- Day One to acquire Mersana for $130 million, $130M (November 30, 2025)
Who to call at QOL Medical, and when
When QOL Medical changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day QOL Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at QOL Medical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at QOL Medical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment QOL Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Evoke Pharma?
Evoke Pharma was acquired by QOL Medical, based in Vero Beach. The deal was reported on December 17, 2025. QOL Medical is a specialty biopharmaceutical company committed to delivering solutions for rare diseases. QOL Medical is privately held and operates in Biotechnology.
When did QOL Medical acquire Evoke Pharma?
QOL Medical's acquisition of Evoke Pharma was reported on December 17, 2025. QOL Medical announced the successful completion of its acquisition of Evoke Pharma, with the transaction concluding on December 15, 2025. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Evoke Pharma do?
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray. It is privately held, operating in Biotechnology, and is based in Solana Beach.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.